Flagship Ventures Opportunities Fund I General Partner LLC, 10% Owner at Evelo Biosciences, Inc. (EVLO), bought 92,857 shares at $15.00 ($1.4M) on 2021-02-02, disclosed to the SEC on 2021-02-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 9,285 | $139K | 10.0% |
| 2 | $15.00 | 37,143 | $557K | 40.0% |
| 3 | $15.00 | 46,429 | $696K | 50.0% |
| Total | $15.00 avg | 92,857 | $1.4M | 100% |
| Filing → |
| FHTX | BUY | 2020-10-29 | $800K | — | Filing → |
| AXLA | BUY | 2020-05-20 | $18.1M | — | Filing → |